MarketInOut Stock Screener Log In | Sign Up
 

Adial Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 15:55
Adial Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.96 mln
Float2.38 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

19 / 100
Significantly lagging

ROE

-2,012
Deeply negative

ROA

-539
Deeply negative

Business Description

Adial Pharmaceuticals is a Virginia-based drug development company working to help people overcome addiction and manage pain without opioids. Its most advanced treatment, AD04, is currently in late-stage clinical trials aimed at reducing harmful alcohol use. Founded in 2010, the company continues to expand its pipeline of potential therapies targeting a range of conditions.

Key Fundamentals

EPS-18.78
ROE-2,012
ROIC-885
ROA-539
EBITDA, mln-57.80
EV / EBITDA-0.85
EV / EBIT-0.85

Quote Details

Last 3.49
Change 0.35 (11.15%)
Open 3.07
Volume 56,270
Turnover 196,382
Average Volume 44,082

Financial Ratios

Leverage Ratio186
Current Ratio5.63
Price / Book90.95

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio3.79
Short % of Float7.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.51% 22 / 100   
1 Month -33.01% 9 / 100   
2 Months 23.32% 94 / 100   
6 Months 114% 99 / 100   
1 Year -63.83% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us